It was found that a variety of gene sites are related to the risk, disease severity, hepatic steatosis and advanced fibrosis of NAFLD, including PNPLA3, TM6SF2, GCKR, MBOAT7, APOC3, HSD17B13, etc. [55–60]. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.